Evaluating the Genetic Component of Ischemic Stroke Subtypes A Family History Study

Background and Purpose— Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may vary by etiologic subtype. We determined the familial aggregation of stroke risk in different stroke phenotypes and...

Full description

Saved in:
Bibliographic Details
Published inStroke (1970) Vol. 34; no. 6; pp. 1364 - 1369
Main Authors Jerrard-Dunne, Paula, Cloud, Geoffrey, Hassan, Ahamad, Markus, Hugh S.
Format Journal Article
LanguageEnglish
Published Hagerstown, MD Lippincott Williams & Wilkins 01.06.2003
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background and Purpose— Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may vary by etiologic subtype. We determined the familial aggregation of stroke risk in different stroke phenotypes and used the results to model estimated sample size requirements for case-control studies. Methods— One thousand consecutive white subjects with ischemic stroke and 800 white controls matched for age and sex were recruited. A first-degree family history of stroke and myocardial infarction was obtained by structured interview. Stroke subtype was determined with the use of modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. Results— A family history of stroke at ≤65 years was a significant risk factor for large-vessel disease (odds ratio [OR], 2.24; 95% CI, 1.49 to 3.36; P <0.001) and for small-vessel disease (OR, 1.93; 95% CI, 1.25 to 2.97; P =0.003). When only cases aged ≤65 years were considered, these ORs increased to 2.93 (95% CI, 1.68 to 5.13) ( P <0.001) and 3.15 (95% CI, 1.81 to 5.50) ( P <0.001), respectively. No significant associations were seen for cardioembolic stroke or stroke of undetermined etiology. Conclusions— A family history of vascular disease is an independent risk factor for both large-vessel atherosclerosis and small-vessel disease, especially in cases presenting before age 65 years. The estimated sample sizes for case-control studies illustrate how candidate gene studies for ischemic stroke might be made more effective by focusing on these specific phenotypes, in which the genetic component of the disease appears to be strongest.
AbstractList Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may vary by etiologic subtype. We determined the familial aggregation of stroke risk in different stroke phenotypes and used the results to model estimated sample size requirements for case-control studies. One thousand consecutive white subjects with ischemic stroke and 800 white controls matched for age and sex were recruited. A first-degree family history of stroke and myocardial infarction was obtained by structured interview. Stroke subtype was determined with the use of modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. A family history of stroke at < or =65 years was a significant risk factor for large-vessel disease (odds ratio [OR], 2.24; 95% CI, 1.49 to 3.36; P<0.001) and for small-vessel disease (OR, 1.93; 95% CI, 1.25 to 2.97; P=0.003). When only cases aged <or =65 years were considered, these ORs increased to 2.93 (95% CI, 1.68 to 5.13) (P<0.001) and 3.15 (95% CI, 1.81 to 5.50) (P<0.001), respectively. No significant associations were seen for cardioembolic stroke or stroke of undetermined etiology. A family history of vascular disease is an independent risk factor for both large-vessel atherosclerosis and small-vessel disease, especially in cases presenting before age 65 years. The estimated sample sizes for case-control studies illustrate how candidate gene studies for ischemic stroke might be made more effective by focusing on these specific phenotypes, in which the genetic component of the disease appears to be strongest.
Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may vary by etiologic subtype. We determined the familial aggregation of stroke risk in different stroke phenotypes and used the results to model estimated sample size requirements for case-control studies.BACKGROUND AND PURPOSETwin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may vary by etiologic subtype. We determined the familial aggregation of stroke risk in different stroke phenotypes and used the results to model estimated sample size requirements for case-control studies.One thousand consecutive white subjects with ischemic stroke and 800 white controls matched for age and sex were recruited. A first-degree family history of stroke and myocardial infarction was obtained by structured interview. Stroke subtype was determined with the use of modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria.METHODSOne thousand consecutive white subjects with ischemic stroke and 800 white controls matched for age and sex were recruited. A first-degree family history of stroke and myocardial infarction was obtained by structured interview. Stroke subtype was determined with the use of modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria.A family history of stroke at < or =65 years was a significant risk factor for large-vessel disease (odds ratio [OR], 2.24; 95% CI, 1.49 to 3.36; P<0.001) and for small-vessel disease (OR, 1.93; 95% CI, 1.25 to 2.97; P=0.003). When only cases aged <or =65 years were considered, these ORs increased to 2.93 (95% CI, 1.68 to 5.13) (P<0.001) and 3.15 (95% CI, 1.81 to 5.50) (P<0.001), respectively. No significant associations were seen for cardioembolic stroke or stroke of undetermined etiology.RESULTSA family history of stroke at < or =65 years was a significant risk factor for large-vessel disease (odds ratio [OR], 2.24; 95% CI, 1.49 to 3.36; P<0.001) and for small-vessel disease (OR, 1.93; 95% CI, 1.25 to 2.97; P=0.003). When only cases aged <or =65 years were considered, these ORs increased to 2.93 (95% CI, 1.68 to 5.13) (P<0.001) and 3.15 (95% CI, 1.81 to 5.50) (P<0.001), respectively. No significant associations were seen for cardioembolic stroke or stroke of undetermined etiology.A family history of vascular disease is an independent risk factor for both large-vessel atherosclerosis and small-vessel disease, especially in cases presenting before age 65 years. The estimated sample sizes for case-control studies illustrate how candidate gene studies for ischemic stroke might be made more effective by focusing on these specific phenotypes, in which the genetic component of the disease appears to be strongest.CONCLUSIONSA family history of vascular disease is an independent risk factor for both large-vessel atherosclerosis and small-vessel disease, especially in cases presenting before age 65 years. The estimated sample sizes for case-control studies illustrate how candidate gene studies for ischemic stroke might be made more effective by focusing on these specific phenotypes, in which the genetic component of the disease appears to be strongest.
Background and Purpose— Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors may vary by etiologic subtype. We determined the familial aggregation of stroke risk in different stroke phenotypes and used the results to model estimated sample size requirements for case-control studies. Methods— One thousand consecutive white subjects with ischemic stroke and 800 white controls matched for age and sex were recruited. A first-degree family history of stroke and myocardial infarction was obtained by structured interview. Stroke subtype was determined with the use of modified Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. Results— A family history of stroke at ≤65 years was a significant risk factor for large-vessel disease (odds ratio [OR], 2.24; 95% CI, 1.49 to 3.36; P <0.001) and for small-vessel disease (OR, 1.93; 95% CI, 1.25 to 2.97; P =0.003). When only cases aged ≤65 years were considered, these ORs increased to 2.93 (95% CI, 1.68 to 5.13) ( P <0.001) and 3.15 (95% CI, 1.81 to 5.50) ( P <0.001), respectively. No significant associations were seen for cardioembolic stroke or stroke of undetermined etiology. Conclusions— A family history of vascular disease is an independent risk factor for both large-vessel atherosclerosis and small-vessel disease, especially in cases presenting before age 65 years. The estimated sample sizes for case-control studies illustrate how candidate gene studies for ischemic stroke might be made more effective by focusing on these specific phenotypes, in which the genetic component of the disease appears to be strongest.
Author Jerrard-Dunne, Paula
Hassan, Ahamad
Markus, Hugh S.
Cloud, Geoffrey
Author_xml – sequence: 1
  givenname: Paula
  surname: Jerrard-Dunne
  fullname: Jerrard-Dunne, Paula
  organization: From the Department of Clinical Neurosciences, St George’s Hospital Medical School, London, UK
– sequence: 2
  givenname: Geoffrey
  surname: Cloud
  fullname: Cloud, Geoffrey
  organization: From the Department of Clinical Neurosciences, St George’s Hospital Medical School, London, UK
– sequence: 3
  givenname: Ahamad
  surname: Hassan
  fullname: Hassan, Ahamad
  organization: From the Department of Clinical Neurosciences, St George’s Hospital Medical School, London, UK
– sequence: 4
  givenname: Hugh S.
  surname: Markus
  fullname: Markus, Hugh S.
  organization: From the Department of Clinical Neurosciences, St George’s Hospital Medical School, London, UK
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14881735$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/12714707$$D View this record in MEDLINE/PubMed
BookMark eNqN0U1LxDAQBuAgiq4ff0GKoLfWTJK2qXhQVlcFQXD3HtLsRKv9WJtU8N-bdVcWPJlLIDwzYebdJ9tt1yIhJ0ATgAzOKSTT2XNClycrcsYTyAspksnNFhlBykQsMia3yYhSXsRMFMUe2XfuLXDGZbpL9oDlIHKaj8jl7aeuB-2r9iXyrxjdYYu-MtG4axbh19ZHnY0enHnFJrxOfd-9YzQdSv-1QHdIdqyuHR6t7wMym9zOxvfx49Pdw_j6MTZcgo_nGZdZhoYLxkGWDHOZFnZuOCLPUJaFRskNtYJTYABUgjZlajPA1KZg-QE5W7Vd9N3HgM6rpnIG61q32A1O5VzQsJgiwOM1HMoG52rRV43uv9TvuAGcroF2Rte2162p3MYJKSHnaXAXK2f6zrke7YZQtcxAUVAhA7XJQP1koCY3ofjqT7GpfNhw1_peV_V_WnwD2UCMmQ
CODEN SJCCA7
CitedBy_id crossref_primary_10_1007_s00439_024_02717_7
crossref_primary_10_1016_j_jns_2009_03_015
crossref_primary_10_1007_BF03256279
crossref_primary_10_1111_j_1747_4949_2009_00281_x
crossref_primary_10_1177_1051228405001473
crossref_primary_10_1007_s12975_010_0041_5
crossref_primary_10_5535_arm_2015_39_6_980
crossref_primary_10_1007_s12013_014_0099_x
crossref_primary_10_1371_journal_pone_0159811
crossref_primary_10_4199_C00052ED1V01Y201204GMM001
crossref_primary_10_1161_STROKEAHA_119_024151
crossref_primary_10_1002_gepi_21729
crossref_primary_10_1177_0193945920957935
crossref_primary_10_3390_ijms21249729
crossref_primary_10_1186_1471_2350_14_17
crossref_primary_10_1016_j_thromres_2014_07_025
crossref_primary_10_1097_01_mol_0000162324_85290_ac
crossref_primary_10_3889_oamjms_2016_114
crossref_primary_10_1016_j_jstrokecerebrovasdis_2008_11_004
crossref_primary_10_1177_1076029617736383
crossref_primary_10_1016_j_jstrokecerebrovasdis_2007_11_001
crossref_primary_10_1038_nrneurol_2014_196
crossref_primary_10_1111_ene_12827
crossref_primary_10_1113_expphysiol_2007_038752
crossref_primary_10_1212_01_wnl_0000252955_17126_6a
crossref_primary_10_1042_CS20160825
crossref_primary_10_1097_HJR_0b013e328330be77
crossref_primary_10_1001_archneurol_2011_99
crossref_primary_10_1097_JCMA_0000000000000598
crossref_primary_10_1016_j_jacc_2010_02_051
crossref_primary_10_1038_ng_1081
crossref_primary_10_1177_1470320309360816
crossref_primary_10_1007_s12013_014_9878_7
crossref_primary_10_1097_MBC_0b013e3282010ad0
crossref_primary_10_1373_clinchem_2006_073494
crossref_primary_10_1038_aps_2010_141
crossref_primary_10_1590_S1980_57642011DN05040003
crossref_primary_10_1097_MOP_0b013e3282f1883b
crossref_primary_10_1155_2012_839151
crossref_primary_10_5853_jos_2015_17_1_7
crossref_primary_10_1038_s41598_017_14355_3
crossref_primary_10_1080_13102818_2020_1809518
crossref_primary_10_1016_j_jstrokecerebrovasdis_2014_06_015
crossref_primary_10_1186_1471_2350_9_110
crossref_primary_10_1186_1471_2377_5_20
crossref_primary_10_1186_1471_2350_8_60
crossref_primary_10_1016_j_cacc_2005_04_003
crossref_primary_10_1016_S1474_4422_07_70028_5
crossref_primary_10_1007_s12031_015_0580_z
crossref_primary_10_1016_j_nrl_2013_04_005
crossref_primary_10_1016_j_atherosclerosis_2008_02_025
crossref_primary_10_1111_j_1600_0404_2006_00672_x
crossref_primary_10_1016_j_nrleng_2013_04_004
crossref_primary_10_4103_1673_5374_228729
crossref_primary_10_2217_pgs_12_14
crossref_primary_10_1042_BSR20171088
crossref_primary_10_1002_gepi_20171
crossref_primary_10_1159_000540085
crossref_primary_10_1002_humu_20666
crossref_primary_10_1007_s12017_014_8330_x
crossref_primary_10_1007_s12031_013_0078_5
crossref_primary_10_1161_STROKEAHA_115_009341
crossref_primary_10_1093_hmg_ddr345
crossref_primary_10_1016_j_jstrokecerebrovasdis_2019_05_006
crossref_primary_10_1186_s12879_017_2455_0
crossref_primary_10_4061_2011_179061
crossref_primary_10_1016_j_thromres_2011_11_030
crossref_primary_10_1016_j_jns_2007_01_037
crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_106151
crossref_primary_10_1007_s11684_010_0013_x
crossref_primary_10_1016_j_clineuro_2006_09_005
crossref_primary_10_1007_s11883_013_0342_8
crossref_primary_10_1016_j_bbacli_2014_12_004
crossref_primary_10_1038_ejhg_2008_27
crossref_primary_10_1016_j_jns_2009_06_013
crossref_primary_10_1089_omi_2015_0083
crossref_primary_10_1111_j_1755_5949_2011_00292_x
crossref_primary_10_1002_ana_24840
crossref_primary_10_1186_s12905_021_01305_5
crossref_primary_10_1007_s12031_015_0520_y
crossref_primary_10_1007_s12035_013_8561_0
crossref_primary_10_1160_TH14_06_0566
crossref_primary_10_1007_s12035_016_9903_5
crossref_primary_10_1016_j_brainres_2019_146594
crossref_primary_10_1080_00207454_2019_1688810
crossref_primary_10_3109_00207454_2014_951042
crossref_primary_10_1212_WNL_0000000000000705
crossref_primary_10_1111_ene_12508
crossref_primary_10_1016_j_acvd_2014_07_047
crossref_primary_10_1093_hmg_ddp582
crossref_primary_10_1161_STROKEAHA_115_009485
crossref_primary_10_1002_ana_21480
crossref_primary_10_1097_CRD_0b013e318239b924
crossref_primary_10_2298_ABS0704303S
crossref_primary_10_1097_00008480_200312000_00002
crossref_primary_10_1007_s00415_006_0048_8
crossref_primary_10_1177_1535370213494650
crossref_primary_10_1111_j_1755_5949_2012_00322_x
crossref_primary_10_1111_j_1600_0404_2008_01127_x
crossref_primary_10_1016_S1474_4422_12_70234_X
crossref_primary_10_1016_j_numecd_2023_01_009
crossref_primary_10_1007_s10072_010_0330_5
crossref_primary_10_1371_journal_pmed_1000225
crossref_primary_10_1016_j_neulet_2005_12_078
crossref_primary_10_1016_S1474_4422_21_00031_4
crossref_primary_10_1371_journal_pone_0090255
crossref_primary_10_1016_S1474_4422_03_00479_4
crossref_primary_10_1055_s_0040_1717116
crossref_primary_10_1371_journal_pone_0001043
crossref_primary_10_1038_nrneurol_2011_80
crossref_primary_10_1371_journal_pgen_1004469
crossref_primary_10_1016_j_pmu_2015_03_002
crossref_primary_10_1186_1741_7015_10_113
crossref_primary_10_1007_s12031_016_0773_0
crossref_primary_10_1371_journal_pone_0136352
crossref_primary_10_1111_ene_12365
crossref_primary_10_1016_j_jstrokecerebrovasdis_2017_05_013
crossref_primary_10_1111_ene_12881
crossref_primary_10_1212_01_wnl_0000178744_42953_b7
crossref_primary_10_1016_S1474_4422_14_70029_8
crossref_primary_10_1038_ng_2397
crossref_primary_10_1177_1747493017743062
crossref_primary_10_1542_peds_2004_1905
crossref_primary_10_1111_j_1747_4949_2010_00422_x
crossref_primary_10_1161_STROKEAHA_116_013148
crossref_primary_10_1161_STROKEAHA_115_009387
crossref_primary_10_1007_s12035_015_9332_x
crossref_primary_10_1016_j_gene_2015_06_036
crossref_primary_10_1080_00207454_2020_1732964
crossref_primary_10_1134_S0362119717080047
crossref_primary_10_1371_journal_pone_0021439
crossref_primary_10_1016_j_jfma_2013_12_004
crossref_primary_10_1007_s11883_009_0027_5
crossref_primary_10_1111_j_1538_7836_2008_03097_x
crossref_primary_10_3892_br_2018_1104
crossref_primary_10_1371_journal_pone_0056478
crossref_primary_10_1161_JAHA_115_003003
crossref_primary_10_3390_ijerph13101016
Cites_doi 10.1161/str.25.9.8073453
10.1093/oxfordjournals.aje.a114224
10.1136/jnnp.62.1.66
10.1161/str.23.2.1561651
10.1161/str.19.11.3188119
10.1093/oxfordjournals.aje.a121625
10.1161/atvb.17.11.2880
10.1161/str.33.3.769
10.1161/str.17.6.3810726
10.1161/circ.91.2.365
10.1056/NEJM198708273170901
10.1093/brain/123.9.1784
10.1161/str.32.12.2939
10.1161/str.24.9.8362432
10.1093/oxfordjournals.aje.a113657
10.1161/str.28.7.1361
10.1097/00004647-200107000-00001
10.1161/str.26.8.1329
10.1161/str.25.8.8042210
10.1159/000110355
10.1161/circ.84.3.1884448
10.1016/S0022-510X(01)00691-8
10.1136/bmj.307.6918.1541
ContentType Journal Article
Copyright 2003 INIST-CNRS
Copyright_xml – notice: 2003 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/01.STR.0000069723.17984.FD
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4628
EndPage 1369
ExternalDocumentID 12714707
14881735
10_1161_01_STR_0000069723_17984_FD
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations London
GeographicLocations_xml – name: London
GroupedDBID ---
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
123
1J1
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5RE
5VS
6PF
71W
77Y
7O~
A9M
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AAQQT
AARTV
AASCR
AASOK
AAUEB
AAXQO
AAYEP
AAYJJ
AAYXX
ABASU
ABBUW
ABDIG
ABJNI
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACDOF
ACEWG
ACGFS
ACGOD
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADGHP
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFFNX
AFMBP
AFNMH
AFSOK
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
AYCSE
BAWUL
BCGUY
BOYCO
BQLVK
BS7
C45
CITATION
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
J5H
JF9
JG8
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
M18
N4W
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB3
OCUKA
ODA
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
R58
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YHZ
YQJ
YYP
ZB8
ZGI
ZZMQN
IQODW
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
OJAPA
OLW
RHF
YCJ
7X8
ID FETCH-LOGICAL-c381t-d63866ec342318b2e7859fdc3ee36e8b9ae83c0f4301211081acb5f61e5f51f3
ISSN 0039-2499
1524-4628
IngestDate Fri Jul 11 09:10:10 EDT 2025
Wed Feb 19 01:44:26 EST 2025
Mon Jul 21 09:17:26 EDT 2025
Thu Apr 24 23:12:21 EDT 2025
Tue Jul 01 01:13:42 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords Human
stroke classification
Nervous system diseases
risk factors
Family study
Cardiovascular disease
Case control study
Epidemiology
Cerebral disorder
Vascular disease
Phenotype
genetics
Ischemia
cerebral infarction
Central nervous system disease
Classification
Risk factor
Cerebrovascular disease
Brain (vertebrata)
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c381t-d63866ec342318b2e7859fdc3ee36e8b9ae83c0f4301211081acb5f61e5f51f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 12714707
PQID 73401169
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_73401169
pubmed_primary_12714707
pascalfrancis_primary_14881735
crossref_primary_10_1161_01_STR_0000069723_17984_FD
crossref_citationtrail_10_1161_01_STR_0000069723_17984_FD
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2003-06-01
PublicationDateYYYYMMDD 2003-06-01
PublicationDate_xml – month: 06
  year: 2003
  text: 2003-06-01
  day: 01
PublicationDecade 2000
PublicationPlace Hagerstown, MD
PublicationPlace_xml – name: Hagerstown, MD
– name: United States
PublicationTitle Stroke (1970)
PublicationTitleAlternate Stroke
PublicationYear 2003
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References e_1_3_2_9_2
e_1_3_2_15_2
e_1_3_2_8_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_17_2
e_1_3_2_6_2
e_1_3_2_18_2
e_1_3_2_19_2
e_1_3_2_1_2
e_1_3_2_20_2
e_1_3_2_10_2
e_1_3_2_21_2
e_1_3_2_5_2
e_1_3_2_22_2
e_1_3_2_4_2
e_1_3_2_12_2
e_1_3_2_23_2
e_1_3_2_3_2
e_1_3_2_13_2
e_1_3_2_24_2
e_1_3_2_2_2
e_1_3_2_14_2
(e_1_3_2_11_2) 1999; 4
References_xml – ident: e_1_3_2_7_2
  doi: 10.1161/str.25.9.8073453
– ident: e_1_3_2_10_2
  doi: 10.1093/oxfordjournals.aje.a114224
– ident: e_1_3_2_14_2
  doi: 10.1136/jnnp.62.1.66
– ident: e_1_3_2_1_2
  doi: 10.1161/str.23.2.1561651
– ident: e_1_3_2_15_2
  doi: 10.1161/str.19.11.3188119
– ident: e_1_3_2_8_2
  doi: 10.1093/oxfordjournals.aje.a121625
– ident: e_1_3_2_21_2
  doi: 10.1161/atvb.17.11.2880
– ident: e_1_3_2_2_2
  doi: 10.1161/str.33.3.769
– ident: e_1_3_2_22_2
  doi: 10.1161/str.17.6.3810726
– ident: e_1_3_2_24_2
  doi: 10.1161/circ.91.2.365
– ident: e_1_3_2_9_2
  doi: 10.1056/NEJM198708273170901
– ident: e_1_3_2_5_2
  doi: 10.1093/brain/123.9.1784
– ident: e_1_3_2_19_2
  doi: 10.1161/str.32.12.2939
– ident: e_1_3_2_3_2
  doi: 10.1161/str.24.9.8362432
– ident: e_1_3_2_16_2
  doi: 10.1093/oxfordjournals.aje.a113657
– ident: e_1_3_2_4_2
  doi: 10.1161/str.28.7.1361
– ident: e_1_3_2_18_2
  doi: 10.1097/00004647-200107000-00001
– ident: e_1_3_2_20_2
  doi: 10.1161/str.26.8.1329
– ident: e_1_3_2_13_2
  doi: 10.1161/str.25.8.8042210
– ident: e_1_3_2_17_2
  doi: 10.1159/000110355
– ident: e_1_3_2_23_2
  doi: 10.1161/circ.84.3.1884448
– ident: e_1_3_2_12_2
  doi: 10.1016/S0022-510X(01)00691-8
– ident: e_1_3_2_6_2
  doi: 10.1136/bmj.307.6918.1541
– volume: 4
  start-page: 313
  year: 1999
  ident: e_1_3_2_11_2
  publication-title: J Epidemiol Biostat
SSID ssj0002385
Score 2.217642
Snippet Background and Purpose— Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is...
Twin and family history studies support a role for genetic factors in stroke risk. Because the etiology of ischemic stroke is heterogeneous, genetic factors...
SourceID proquest
pubmed
pascalfrancis
crossref
SourceType Aggregation Database
Index Database
Enrichment Source
StartPage 1364
SubjectTerms Aged
Biological and medical sciences
Brain Ischemia - classification
Brain Ischemia - epidemiology
Brain Ischemia - genetics
Case-Control Studies
European Continental Ancestry Group - genetics
Family
Female
Gene Frequency
Humans
Ischemic Attack, Transient - epidemiology
Ischemic Attack, Transient - genetics
London - epidemiology
Male
Medical sciences
Middle Aged
Multivariate Analysis
Neurology
Odds Ratio
Risk
Risk Factors
Sample Size
Stroke - classification
Stroke - epidemiology
Stroke - genetics
Vascular Diseases - epidemiology
Vascular Diseases - genetics
Vascular diseases and vascular malformations of the nervous system
Subtitle A Family History Study
Title Evaluating the Genetic Component of Ischemic Stroke Subtypes
URI https://www.ncbi.nlm.nih.gov/pubmed/12714707
https://www.proquest.com/docview/73401169
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkRASQrwJj7IHbsgm6_WTW0UbRUVFghipN2tfVqvSOIrtQ_vrmX0461AiFS5WZGdta-fb8czszDcIfQCVx7KEyyBKIhnEIpFBDlZ_oCTXMTcxrakuTj75ls5_xsenyakP6Jvqko6H4vqvdSX_I1U4B3LVVbL_INnNTeEE_Ab5whEkDMdbyfjIUXW7iif4ny5JNGnizdJt8p-D-2oS4Ntu3Vyoj23Pddi1tVXOLr5hWYevRmSzzl5d2EGazanIpqOwwbHS_eFloA1gNaQYjrJ-ml66kLupFPOKrm1tyPXgjF0y6QPi64veQGquuwYttoIR1CdNhcop0CgOdL3rWMO6cOX5DXVJqKUwv6nHU2JqE8JF-cNSTKa6PVqo6dXicHY4HgTztbo0EiZRRuLMdtH9g0V7uHQX3YvAodC9Lr5-97zyYLgkjpIWHv1p94M1yay71ZYl83DFWlhUte2GsttdMWZL-Rg9cv4GPrDgeYLuqOVTdP_EZVQ8Q6XHEAYMYYchvMEQbmo8YAhbDOEBQ58xwxZB2CEIGwQ9R-XsqPwyD1ynjUCAxdYFErRwmiqh6SBJziOV5UlRS0GVoqnKecFUrtdtTA0lIJiRTPCkTolK6oTU9AXaW8I7vdKZcqxgaZyxKTiqAj4HnOcqN2GGPJJSTFAxTFolHAu9bobyqzLeaEqqKalg7is_95WZ-2p2OEF0M3ZluVhuNWp_SzZ-KHy7SEaTCXo_CKsC3ao3zNhSNX1bZTTW-5TFBL20MvRjHQZe77zyBj3wC-Qt2uvWvXoH9mvH9w30fgPCg5Mc
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evaluating+the+genetic+component+of+ischemic+stroke+subtypes%3A+a+family+history+study&rft.jtitle=Stroke+%281970%29&rft.au=Jerrard-Dunne%2C+Paula&rft.au=Cloud%2C+Geoffrey&rft.au=Hassan%2C+Ahamad&rft.au=Markus%2C+Hugh+S&rft.date=2003-06-01&rft.eissn=1524-4628&rft.volume=34&rft.issue=6&rft.spage=1364&rft_id=info:doi/10.1161%2F01.STR.0000069723.17984.FD&rft_id=info%3Apmid%2F12714707&rft.externalDocID=12714707
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0039-2499&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0039-2499&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0039-2499&client=summon